Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism
- PMID: 8968075
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism
Abstract
Aberrant glycosylation expressed in glycosphingolipids and glycoproteins in tumor cells has been implicated as an essential mechanism in defining stage, direction, and fate of tumor progression. This general concept is supported by results from three lines of study: (a) Numerous clinicopathological studies have shown a clear correlation between aberrant glycosylation status of primary tumor and invasive/metastatic potential of human cancer as reflected by 5- or 10-year survival rates of patients. (b) Carbohydrates expressed in tumor cells are either adhesion molecules per se or modulate adhesion receptor function. Some are directly involved in cell adhesion. They are recognized by selectins or other carbohydrate-binding proteins or by complementary carbohydrates (through carbohydrate-carbohydrate interaction). N- or O-glycosylation of functionally important membrane components may alter tumor cell adhesion or motility in a direction that either promotes or inhibits invasion and metastasis. Examples of such receptors are E-cadherin, integrins, immunoglobulin family receptors (e.g., CD44), and lysosome-associated membrane protein. (c) Gangliosides and sphingolipids modulate transmembrane signaling essential for tumor cell growth, invasion, and metastasis. The transducer molecules susceptible to gangliosides and sphingolipids include integrin receptors, tyrosine kinase-linked growth factor receptors, protein kinase C, and G-protein-linked receptor affecting protein kinase A. Some glycosphingolipids (e.g., Gb3Cer, Le(y), ceramide, and sphingosine induce tumor cell differentiation and subsequent apoptosis. Shedded gangliosides may block immunogenicity of tumor cells, providing conditions favorable for "escape" from immunological suppression of tumor growth by the host. Various reagents that block carbohydrate-mediated tumor cell adhesion or block glycosylation processing have been shown to inhibit tumor cell metastasis. This provides the basis for further development of "anti-adhesion therapy." Ganglioside analogues and sphingolipid analogues that inhibit protein kinase C and receptor-associated tyrosine kinase have been applied for inhibition of metastasis. A crucial mechanism for inhibition of metastasis by these reagents may involve blocking of transmembrane signaling for expression of P- and E-selectin. This provides the basis for development of "ortho-signaling therapy."
Similar articles
-
New directions in cancer therapy based on aberrant expression of glycosphingolipids: anti-adhesion and ortho-signaling therapy.Cancer Cells. 1991 Dec;3(12):461-70. Cancer Cells. 1991. PMID: 1820092 Review.
-
Disialosyl galactosylgloboside as an adhesion molecule expressed on renal cell carcinoma and its relationship to metastatic potential.Cancer Res. 1996 Apr 15;56(8):1932-8. Cancer Res. 1996. PMID: 8620516
-
Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.Clin Cancer Res. 2006 Mar 1;12(5):1479-86. doi: 10.1158/1078-0432.CCR-05-1519. Clin Cancer Res. 2006. PMID: 16533771
-
B lymphocyte binding to E- and P-selectins is mediated through the de novo expression of carbohydrates on in vitro and in vivo activated human B cells.J Clin Invest. 1994 Oct;94(4):1585-96. doi: 10.1172/JCI117500. J Clin Invest. 1994. PMID: 7523454 Free PMC article.
-
Adhesion molecules in tumor metastasis.Semin Cancer Biol. 1993 Aug;4(4):219-29. Semin Cancer Biol. 1993. PMID: 8400144 Review.
Cited by
-
Serum Lipidome Profiling Reveals a Distinct Signature of Ovarian Cancer in Korean Women.Cancer Epidemiol Biomarkers Prev. 2024 May 1;33(5):681-693. doi: 10.1158/1055-9965.EPI-23-1293. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38412029 Free PMC article.
-
BIRTH OF A GLYCOTHERAPY FOR BREAST CANCER.Trends Carbohydr Res. 2023;15:25-37. Trends Carbohydr Res. 2023. PMID: 38362162 Free PMC article.
-
Glycocalyx analysis of bladder cancer: three-dimensional images in electron microscopy and vicia villosa lectin as a marker for invasiveness in frozen sections.Front Cell Dev Biol. 2024 Jan 10;11:1308879. doi: 10.3389/fcell.2023.1308879. eCollection 2023. Front Cell Dev Biol. 2024. PMID: 38269087 Free PMC article.
-
Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system.Mol Oncol. 2024 Mar;18(3):528-546. doi: 10.1002/1878-0261.13569. Epub 2023 Dec 26. Mol Oncol. 2024. PMID: 38115217 Free PMC article.
-
Regulatory mechanism for the human glioblastoma cell-specific expression of the human GD1c/GT1a/GQ1b synthase (hST8Sia V) gene.Glycoconj J. 2023 Dec;40(6):621-630. doi: 10.1007/s10719-023-10136-5. Epub 2023 Nov 3. Glycoconj J. 2023. PMID: 37921922
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous